𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors (E9292): A Trial of the Eastern Cooperative Oncology Group

✍ Scribed by Keith Stuart; Donna E. Levy; Tom Anderson; Constantine A. Axiotis; Janice P. Dutcher; Andrew Eisenberg; John K. Erban; Al Bowen Benson

Book ID
111579887
Publisher
Springer US
Year
2004
Tongue
English
Weight
82 KB
Volume
22
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of taxol in salivary glan
Phase II trial of taxol in salivary gland malignancies (E1394): A trial of the Eastern Cooperative Oncology Group
✍ Jill Gilbert; Yi Li; Harlan A. Pinto; Timothy Jennings; Merrill S. Kies; Paula S πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 1 views

## Background: Malignant tumors of the salivary glands make up approximately 5% of head and neck cancers. the eastern cooperative oncology group (ecog) initiated a phase ii evaluation of paclitaxel in patients with locally recurrent or metastatic salivary gland malignancies. ## Methods: Chemo-nai

Phase II trial of PCNU in advanced malig
Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study
✍ Robert H. Earhart; Franco M. Muggia; Frederick M. Golomb πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 327 KB

PCNU, a chloroethylnitrosourea with high alkylating activity, low carbamoylating activity, optimal octanol: water partition coefficient and broad activity in animal systems, was administered to 32 evaluable patients with measurable metastatic melanoma by brief intravenous infusions every six weeks.

Phase II study of Ξ±2 interferon in the t
Phase II study of Ξ±2 interferon in the treatment of the chronic myeloproliferative disorders (E5487) : A trial of the Eastern Cooperative Oncology Group
✍ Arthur I. Radin; Haesook T. Kim; Barbara W. Grant; John M. Bennett; John M. Kirk πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

## Abstract ## BACKGROUND In vitro and clinical data suggest a therapeutic role for Ξ±2 interferon (IFN) in the treatment of the chronic myeloproliferative disorders. Accordingly, a multiinstitutional, Phase II trial of IFN in patients with agnogenic myeloid metaplasia (AMM), essential thrombocythe

Phase II trial of gemcitabine in patient
Phase II trial of gemcitabine in patients with advanced sarcomas (E1797) : A trial of the Eastern Cooperative Oncology Group
✍ Scott Okuno; Louise M. Ryan; John H. Edmonson; Dennis A. Priebat; Ronald H. Blum πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The current study was conducted to evaluate the antitumor activity and toxicity of gemcitabine in patients with advanced sarcoma. ## METHODS Twenty‐five patients with advanced sarcomas, who previously were untreated for metastatic disease, were treated on an Eastern Coo